The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Cyberonics to Present at 23rd Annual Piper Jaffray Health Care Conference

Wednesday, November 16, 2011

Cyberonics to Present at 23rd Annual Piper Jaffray Health Care Conference09:00 EST Wednesday, November 16, 2011HOUSTON, Nov. 16, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011, in New York.Dan Moore, President and Chief Executive Officer, and Greg Browne, Senior Vice President and Chief Financial Officer, will speak at 8:30 AM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on November 30, 2011.  No slides will be presented at the conference.  About Cyberonics, Inc. and the VNS Therapy® SystemCyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.Contact InformationGreg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd.Houston, TX 77058Main:  (281) 228-7262Fax:  (281) 218-9332ir@cyberonics.comSOURCE Cyberonics, Inc.